Status: Recruiting
Impact of Pilates Exercises on Bone Mineral Density in Breast Cancer Survivors Receiving Hormonal Therapy
Breast cancer survivors receiving endocrine (hormonal) therapy (aromatase inhibitors) are at high risk for cancer treatment-induced bone loss and osteoporosis due to estrogen depletion.
Participants needed: 60
Trial details
Age: 40-60Biological sex: FemaleType: InterventionalSponsor: Benha UniversityUpdated: Jan 15, 2026Locations: 1
Eligibility criteria
Female breast cancer survivors aged 40-60 years. [+6]
Metastatic (stage IV) or recurrent breast cancer. [+8]